Clinical Trials Browser

Bone Neoplasms × anlotinib × Sarcoma × Clear all

NCT03527888 2019-05-21

Study of Anlotinib in Patients With Primary Malignant Bone Tumors

Phase 2 Unknown

Bone Neoplasms